The JAK1/JAK2-inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release

Research output: Contribution to journal › Article › Academic › peer-review

37 Citations (Scopus)

6 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1412-1420
Number of pages	9
Journal	Clinical & Experimental Allergy
Volume	48
Issue number	11
DOIs	https://doi.org/10.1111/cea.13217
Publication status	Published - 2018

Access to Document

@article{677277748bc94831898b5f6829387c9e,

title = "The JAK1/JAK2-inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release",

author = "Maud Hermans and Benjamin Schrijver and Conny Neelen and {Gerth van Wijk}, Roy and {van Hagen}, P.M. and {van Daele}, Paul and Wim Dik",

year = "2018",

doi = "10.1111/cea.13217",

language = "Undefined/Unknown",

volume = "48",

pages = "1412--1420",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "11",

}

TY - JOUR

T1 - The JAK1/JAK2-inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release

AU - Hermans, Maud

AU - Schrijver, Benjamin

AU - Neelen, Conny

AU - Gerth van Wijk, Roy

AU - van Hagen, P.M.

AU - van Daele, Paul

AU - Dik, Wim

PY - 2018

Y1 - 2018

U2 - 10.1111/cea.13217

DO - 10.1111/cea.13217

M3 - Article

VL - 48

SP - 1412

EP - 1420

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 11

ER -